Zinc Iodide in combination with Dimethyl Sulfoxide for treatment of SARS-CoV-2 and other viral infections
- 23 May 2020
- journal article
- research article
- Published by Elsevier BV in Medical Hypotheses
- Vol. 143, 109866
- https://doi.org/10.1016/j.mehy.2020.109866
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Enhancement of Respiratory Mucosal Antiviral Defenses by the Oxidation of IodideAmerican Journal of Respiratory Cell and Molecular Biology, 2011
- Dimethyl Sulfoxide and Sodium Bicarbonate in the Treatment of Refractory Cancer PainJournal of Pain & Palliative Care Pharmacotherapy, 2011
- Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell CulturePLoS Pathogens, 2010
- Zinc: role in immunity, oxidative stress and chronic inflammationCurrent Opinion in Clinical Nutrition and Metabolic Care, 2009
- The Nuclear Factor NF- B Pathway in InflammationCold Spring Harbor Perspectives in Biology, 2009
- Antiviral Activity of the Zinc Ionophores Pyrithione and Hinokitiol against Picornavirus InfectionsJournal of Virology, 2009
- PDTC inhibits picornavirus polyprotein processing and RNA replication by transporting zinc ions into cellsJournal of General Virology, 2007
- Cellular and Molecular Dynamics in the Foreign Body ReactionTissue Engineering, 2006
- Effects of Betaisodona® on Parameters of Host DefenseDermatology, 1997
- Inhibition of the Particle-associated RNA-dependent RNA Polymerase Activity of Influenza Viruses by Chelating AgentsJournal of General Virology, 1974